Cite

HARVARD Citation

    Furlanetto, J. et al. (2021). Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy. European journal of cancer. pp. 44-52. [Online]. 
  
Back to record